Exclusive: UBS gets fresh US pensions licence fixing paperwork error, filings show
The U.S. Department of Labor granted UBS a waiver the Swiss bank needs to continue managing U.S. retirement plans after a ...
Former UBS director says FIRE isn’t worth it because ‘you’ll get bored very quickly’
Eric Sim, formerly a managing director at UBS, said people working doggedly towards retirement without knowing what they'll ...
Siegel-WisdomTree Models Now Available at UBS
The Siegel-WisdomTree Model Portfolios are now available on the UBS Financial Services Inc. separately managed account ...
CPI report feels like we're back in goldilocks scenario, says UBS' Mark Andersen
Mark Andersen, UBS Global Wealth Management co-head of global asset allocation, joins 'Money Movers' to discuss Wednesday's ...
UBS Advisor Team Montage Financial Group Named to Forbes Top Wealth Management Teams Private Wealth List
UBS Wealth Management US announced today that financial advisor team Montage Financial Group has been named to the Forbes ...
UBS Seems Set to Keep Its Promises to Shareholders
(Bloomberg Opinion) -- The big question for UBS Group AG shareholders is how badly its share buyback promises will be knocked ...
Emerging Markets Face Further Losses on Trump Tariffs, UBS Says
Emerging-market equities and currencies are vulnerable to further losses as the recent selloff hasn’t fully priced in risks ...
WealthManagement.com2h
The Diamond Podcast for Financial Advisors: $6B+ Former UBS Team Finds Freedom to Focus on Clients
Tony Smith of Stonegate Investment Group discusses transitioning from UBS after 14 years and $4.4 billion in AUM to ...
UBS Nears Settlement Over Credit Suisse Tax Evasion Case, WSJ Reports
(Reuters) - UBS is set to pay a minimum of hundreds of millions of dollars to settle Credit Suisse's violations of an earlier ...
Budget 2025: Will market rally? Here's what UBS expects
UBS predicts that the Budgets focus on fiscal discipline may dampen market sentiment, particularly if FY26 capital ...
UBS cuts rating on Regeneron stock amid Eylea uncertainty
Investing.com -- UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to "Neutral" from "Buy" given uncertainty ...
Underlying trends remain favorable for equities: UBS
The choppy start to 2025 for the stock market has not been caused by any fundamentally negative economic news, and underlying trends remain favorable for equities, according to Solita Marcelli, chief ...